Taking into account the statistically significant increase of IL-8 and MMP-9 concentrations in the peripheral blood of patients at stage II and III adenocarcinoma, the actual distribution of these two molecules was then verified in a limited number of corresponding CRC sections by immunohistochemistry. The gene discussed is CXCL8; the disease is colorectal carcinoma.